OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Hematology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	39
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	26
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	25
Deficits in our understanding of natural killer cell development in mouse and human	23
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	22
Age-dependent regulation of hematopoiesis by megakaryocytes	21
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	21
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	21
Disparities in acute myeloid leukemia treatments and outcomes	18
Developmental regulation of primitive erythropoiesis	18
Mesenchymal stromal cells: an update	17
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	16
Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives	16
Confronting high-complexity situations in myeloproliferative neoplasms: from treating young patients to TP53-mutated and ‘unclassifiable’ entities	15
The impact of obesity-induced inflammation on clonal hematopoiesis	15
Unraveling lipid metabolism for acute myeloid leukemia therapy	15
Platelet lifespan and mechanisms for clearance	14
Humanized murine models of platelet function	13
Multifaceted roles of CRISPR technology in blood cancer research	13
Advances on the genetic basis of red cell membrane disorders	12
Navigating prognostic stratification and approach to TP53-mutated myeloid neoplasms	12
Messengers of coagulopathy: complement-carrying extracellular vesicles in SARS-CoV-2 infection	11
High-throughput genotyping tools for red blood cell antigens	11
Stress granules and RNA modifications in blood development and erythroid regeneration	11
Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells	11

Editorial introduction	10
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	10
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	9
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	9
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	9
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	9
Cellular contributions to the pathogenesis of anti-platelet factor 4 disorders	9
Understanding and targeting erythroid progenitor cells for effective cancer therapy	9
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	9
Editorial introductions	8
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	8
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	8
YY1 in hematopoietic stem cells: epigenetic regulation, chromatin architecture, and aging	8
Red blood cell changes due to cancer and cancer treatments: a narrative review	7
Modelling arterial thrombus formation in vitro	7
The immunology of PF4 polyanion interactions	7
Protease-activated receptors in endothelial health and dysfunction	7
Current Opinion in Hematology	7
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	7
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	7
Platelet mitochondria: the mighty few	6
The state of prediction models in hematologic disease: a worrisome assessment	6
Membrane phospholipids in the regulation of tissue factor procoagulant function	6
The fulfilled promise and unmet potential of umbilical cord blood	6
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	6
Platelet transfusion	6
Models to study myelodysplastic syndrome and acute myeloid leukaemia	6
Platelets and platelet–leukocyte interactions in infectious diseases	6
Chediak-Higashi syndrome	6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	6
Editorial introduction	6
Immunomodulatory roles of red blood cells	6